CLPTM1 Recombinant Antibody, AbBy Fluor™ 350 Conjugated
Product Specifications
Background
Involved in GABAergic but not glutamatergic transmission. Binds and traps GABAA receptors in the endoplasmic reticulum (ER) . Modulates postsynaptic GABAergic transmission, and therefore inhibitory neurotransmission, by reducing the plasma membrane expression of these receptors. Altered GABAergic signaling is one among many causes of cleft palate.
Synonyms
HS9; N14.
Gene ID
1209
Swiss Prot
O96005
Host
Rabbit
Cross Reactivity
Human
Target
CLPTM1
Clonality
Recombinant
Conjugation
AbBy Fluor™ 350
Source
KLH conjugated synthetic peptide derived from human Putative lipid scramblase CLPTM1
Applications
WB, IF, Flow-Cyt
Purification
Purified by Protein A.
Excitation Emission
346nm/442nm
Concentration
Lot dependent
Dilution
WB (1:300-5000), IF (), Flow-Cyt (1ug/Test)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
1209
Isotype
IgG
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6139795-01 0.1 mL
USP31 (Ubiquitin-specific-processing Protease 31, Ubiquitin Carboxyl-terminal Hydrolase 31, Deubiquitinating Enzyme 31, Ubiquitin Thioesterase 31, KIAA1203) APC
Ask
View Details MBS6139795-02 5x 0.1 mL
USP31 (Ubiquitin-specific-processing Protease 31, Ubiquitin Carboxyl-terminal Hydrolase 31, Deubiquitinating Enzyme 31, Ubiquitin Thioesterase 31, KIAA1203) APC
Ask
View Details 